AB116. Clinical efficacy and safety of molecular targeted drugs as first-line treatment for mRCC: a systematic review and network meta-analysis

OBJECTIVES: To compare five molecular targeted drugs (MTD) with interferon-α (IFN-α) and evaluate their clinical efficacy and adverse events as first line therapy for metastatic renal cell carcinoma (mRCC). METHODS: We conducted a systemic review and network meta-analysis of all relevant randomized...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Androl Urol
Main Authors: Mo, Chengqiang, Sheng, Jin, Tan, Wulin, Liu, Jingchao, Yu, Zhou, Chen, Xu, Mao, Xiaopeng, Qiu, Shaopeng
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2014
Teme:
Abstract Publication Urology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4708498/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-4683.2014.s116
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki